| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10013213 | HBV | ENSG00000126218.12 | protein_coding | F10 | No | No | 2159 | P00742 Q5JVE7 Q5JVE8 |
| TVIS10020895 | HBV | ENSG00000126218.12 | protein_coding | F10 | No | No | 2159 | P00742 Q5JVE7 Q5JVE8 |
| TVIS30020164 | HIV | ENSG00000126218.12 | protein_coding | F10 | No | No | 2159 | P00742 Q5JVE7 Q5JVE8 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | F10 |
|---|---|
| DrugBank ID | DB06605 |
| Drug Name | Apixaban |
| Target ID | BE0000216 |
| UniProt ID | P00742 |
| Regulation Type | inhibitor |
| PubMed IDs | 17371192; 18393142 |
| Citations | Spyropoulos AC: Investigational treatments of venous thromboembolism. Expert Opin Investig Drugs. 2007 Apr;16(4):431-40.@@Harenberg J, Wehling M: Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Semin Thromb Hemost. 2008 Feb;34(1):39-57. doi: 10.1055/s-2008-1066023. |
| Groups | Approved |
| Direct Classification | Phenylpiperidines |
| SMILES | COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O |
| Pathways | |
| PharmGKB | PA166163740 |
| ChEMBL | CHEMBL231779 |
